annual accounts payable:
$38.76M-$3.36M(-7.97%)Summary
- As of today (July 6, 2025), RARE annual accounts payable is $38.76 million, with the most recent change of -$3.36 million (-7.97%) on December 31, 2024.
- During the last 3 years, RARE annual accounts payable has risen by +$21.62 million (+126.14%).
- RARE annual accounts payable is now -10.44% below its all-time high of $43.27 million, reached on December 31, 2022.
Performance
RARE Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$47.45M+$8.69M(+22.43%)Summary
- As of today (July 6, 2025), RARE quarterly accounts payable is $47.45 million, with the most recent change of +$8.69 million (+22.43%) on March 31, 2025.
- Over the past year, RARE quarterly accounts payable has increased by +$6.48 million (+15.81%).
- RARE quarterly accounts payable is now -20.66% below its all-time high of $59.81 million, reached on June 30, 2024.
Performance
RARE quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
RARE Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.0% | +15.8% |
| 3 y3 years | +126.1% | +100.3% |
| 5 y5 years | +201.1% | +229.4% |
RARE Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.4% | +126.1% | -20.7% | +101.6% |
| 5 y | 5-year | -10.4% | +201.1% | -20.7% | +426.4% |
| alltime | all time | -10.4% | >+9999.0% | -20.7% | +3854.2% |
RARE Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $47.45M(+22.4%) |
| Dec 2024 | $38.76M(-8.0%) | $38.76M(+7.7%) |
| Sep 2024 | - | $35.99M(-39.8%) |
| Jun 2024 | - | $59.81M(+46.0%) |
| Mar 2024 | - | $40.97M(-2.7%) |
| Dec 2023 | $42.11M(-2.7%) | $42.11M(+26.3%) |
| Sep 2023 | - | $33.36M(-20.8%) |
| Jun 2023 | - | $42.12M(-28.6%) |
| Mar 2023 | - | $58.98M(+36.3%) |
| Dec 2022 | $43.27M(+152.5%) | $43.27M(+83.9%) |
| Sep 2022 | - | $23.53M(-31.2%) |
| Jun 2022 | - | $34.21M(+44.5%) |
| Mar 2022 | - | $23.68M(+38.2%) |
| Dec 2021 | $17.14M(+32.6%) | $17.14M(+10.0%) |
| Sep 2021 | - | $15.57M(-28.5%) |
| Jun 2021 | - | $21.79M(+38.4%) |
| Mar 2021 | - | $15.74M(+21.8%) |
| Dec 2020 | $12.92M(+0.4%) | $12.92M(+19.1%) |
| Sep 2020 | - | $10.85M(+20.4%) |
| Jun 2020 | - | $9.01M(-37.4%) |
| Mar 2020 | - | $14.40M(+11.9%) |
| Dec 2019 | $12.87M | $12.87M(-4.4%) |
| Sep 2019 | - | $13.46M(+54.0%) |
| Jun 2019 | - | $8.74M(-31.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $12.66M(+3.2%) |
| Dec 2018 | $12.28M(+38.1%) | $12.28M(+49.7%) |
| Sep 2018 | - | $8.20M(-20.5%) |
| Jun 2018 | - | $10.31M(+36.3%) |
| Mar 2018 | - | $7.57M(-14.8%) |
| Dec 2017 | $8.89M(+65.7%) | $8.89M(-4.3%) |
| Sep 2017 | - | $9.29M(-21.8%) |
| Jun 2017 | - | $11.88M(+42.3%) |
| Mar 2017 | - | $8.35M(+55.6%) |
| Dec 2016 | $5.36M(+82.3%) | $5.36M(-18.9%) |
| Sep 2016 | - | $6.62M(-4.9%) |
| Jun 2016 | - | $6.95M(+15.7%) |
| Mar 2016 | - | $6.01M(+104.4%) |
| Dec 2015 | $2.94M(-39.4%) | $2.94M(-33.5%) |
| Sep 2015 | - | $4.42M(-56.5%) |
| Jun 2015 | - | $10.17M(+76.7%) |
| Mar 2015 | - | $5.75M(+18.5%) |
| Dec 2014 | $4.86M(+238.0%) | $4.86M(+16.7%) |
| Sep 2014 | - | $4.16M(+15.9%) |
| Jun 2014 | - | $3.59M(+2.7%) |
| Mar 2014 | - | $3.50M(+143.2%) |
| Dec 2013 | $1.44M(+19.8%) | $1.44M(-50.3%) |
| Sep 2013 | - | $2.89M(+140.8%) |
| Dec 2012 | $1.20M(+250.9%) | $1.20M |
| Dec 2011 | $342.00K | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual accounts payable?
- What is the all time high annual accounts payable for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual accounts payable year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly accounts payable?
- What is the all time high quarterly accounts payable for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly accounts payable year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual accounts payable?
The current annual accounts payable of RARE is $38.76M
What is the all time high annual accounts payable for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual accounts payable is $43.27M
What is Ultragenyx Pharmaceutical Inc. annual accounts payable year-on-year change?
Over the past year, RARE annual accounts payable has changed by -$3.36M (-7.97%)
What is Ultragenyx Pharmaceutical Inc. quarterly accounts payable?
The current quarterly accounts payable of RARE is $47.45M
What is the all time high quarterly accounts payable for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly accounts payable is $59.81M
What is Ultragenyx Pharmaceutical Inc. quarterly accounts payable year-on-year change?
Over the past year, RARE quarterly accounts payable has changed by +$6.48M (+15.81%)